SCHEMBL7047685

SCHEMBL7047685

CC(C)(C)c1ccc(COc2cccc(C(=O)Nc3ccccc3S(=O)(=O)NC(=O)C=Cc3ccccc3)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.53
NR4A2 P43354 1/20 0.53
NR4A3 Q92570 1/20 0.53
SENP1 Q9P0U3 1/20 0.53
HDAC1 Q13547 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
POLB P06746 2/20 0.46
BCL2L1 Q07817 2/20 0.46
MCL1 Q07820 2/20 0.46
SPHK2 Q9NRA0 1/20 0.46
SPHK1 Q9NYA1 1/20 0.46
SMPD1 P17405 3/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 1/20 0.46
TSHR P16473 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NR1H4 Q96RI1 2/20 0.44
BCHE P06276 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7076267 1.00 NR4A1 (0.53) NR4A1NR4A2NR4A3SENP1HDAC1
SCHEMBL7048541 0.87 NR4A1 (0.57) NR4A1NR4A2NR4A3HDAC1HDAC8
SCHEMBL7050487 0.86 NR4A1 (0.56) NR4A1NR4A2NR4A3HDAC1HDAC8
SCHEMBL7045604 0.84 SMPD1 (0.61) NR4A2HDAC1HDAC8HDAC6POLB
SCHEMBL7052824 0.83 SMPD1 (0.62) NR4A2HDAC1HDAC8HDAC6BCL2L1
SCHEMBL7076910 0.82 HDAC1 (0.59) HDAC1HDAC8HDAC6POLBBCL2L1
SCHEMBL7046419 0.82 CA1 (0.66) NR4A1NR4A2NR4A3HDAC1HDAC8
SCHEMBL7045688 0.81 BCL2L1 (0.63) NR4A1NR4A2NR4A3HDAC1HDAC8
SCHEMBL7047668 0.81 NR4A1 (0.51) NR4A1NR4A2NR4A3HDAC1HDAC8
SCHEMBL7045371 0.81 KMT2A (0.62) NR4A2HDAC1HDAC8HDAC6POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN NR4A1 1480/4885NR4A2 2332/4885NR4A3 2214/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 NR4A1 3224/4885NR4A2 3157/4885NR4A3 3215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.